Gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	MS evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific NX	RNA single cell type specificity	RNA single cell type distribution	RNA single cell type specificity score	RNA single cell type specific NX	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific NX	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific NX	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific NX	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific NX	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific pTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific pTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	CCD Protein	CCD Transcript	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Subcellular main location	Subcellular additional location	Antibody RRID	Pathology prognostics - Breast cancer	Pathology prognostics - Cervical cancer	Pathology prognostics - Colorectal cancer	Pathology prognostics - Endometrial cancer	Pathology prognostics - Glioma	Pathology prognostics - Head and neck cancer	Pathology prognostics - Liver cancer	Pathology prognostics - Lung cancer	Pathology prognostics - Melanoma	Pathology prognostics - Ovarian cancer	Pathology prognostics - Pancreatic cancer	Pathology prognostics - Prostate cancer	Pathology prognostics - Renal cancer	Pathology prognostics - Stomach cancer	Pathology prognostics - Testis cancer	Pathology prognostics - Thyroid cancer	Pathology prognostics - Urothelial cancer	Tissue RNA - adipose tissue [NX]	Tissue RNA - adrenal gland [NX]	Tissue RNA - amygdala [NX]	Tissue RNA - appendix [NX]	Tissue RNA - basal ganglia [NX]	Tissue RNA - bone marrow [NX]	Tissue RNA - breast [NX]	Tissue RNA - cerebellum [NX]	Tissue RNA - cerebral cortex [NX]	Tissue RNA - cervix, uterine [NX]	Tissue RNA - colon [NX]	Tissue RNA - corpus callosum [NX]	Tissue RNA - ductus deferens [NX]	Tissue RNA - duodenum [NX]	Tissue RNA - endometrium 1 [NX]	Tissue RNA - epididymis [NX]	Tissue RNA - esophagus [NX]	Tissue RNA - fallopian tube [NX]	Tissue RNA - gallbladder [NX]	Tissue RNA - heart muscle [NX]	Tissue RNA - hippocampal formation [NX]	Tissue RNA - hypothalamus [NX]	Tissue RNA - kidney [NX]	Tissue RNA - liver [NX]	Tissue RNA - lung [NX]	Tissue RNA - lymph node [NX]	Tissue RNA - midbrain [NX]	Tissue RNA - olfactory region [NX]	Tissue RNA - ovary [NX]	Tissue RNA - pancreas [NX]	Tissue RNA - parathyroid gland [NX]	Tissue RNA - pituitary gland [NX]	Tissue RNA - placenta [NX]	Tissue RNA - pons and medulla [NX]	Tissue RNA - prostate [NX]	Tissue RNA - rectum [NX]	Tissue RNA - retina [NX]	Tissue RNA - salivary gland [NX]	Tissue RNA - seminal vesicle [NX]	Tissue RNA - skeletal muscle [NX]	Tissue RNA - skin 1 [NX]	Tissue RNA - small intestine [NX]	Tissue RNA - smooth muscle [NX]	Tissue RNA - spinal cord [NX]	Tissue RNA - spleen [NX]	Tissue RNA - stomach 1 [NX]	Tissue RNA - testis [NX]	Tissue RNA - thalamus [NX]	Tissue RNA - thymus [NX]	Tissue RNA - thyroid gland [NX]	Tissue RNA - tongue [NX]	Tissue RNA - tonsil [NX]	Tissue RNA - urinary bladder [NX]	Tissue RNA - vagina [NX]	Tissue RNA - B-cells [NX]	Tissue RNA - dendritic cells [NX]	Tissue RNA - granulocytes [NX]	Tissue RNA - monocytes [NX]	Tissue RNA - NK-cells [NX]	Tissue RNA - T-cells [NX]	Tissue RNA - total PBMC [NX]	Cell RNA - A-431 [NX]	Cell RNA - A549 [NX]	Cell RNA - AF22 [NX]	Cell RNA - AN3-CA [NX]	Cell RNA - ASC diff [NX]	Cell RNA - ASC TERT1 [NX]	Cell RNA - BEWO [NX]	Cell RNA - BJ [NX]	Cell RNA - BJ hTERT+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]	Cell RNA - CACO-2 [NX]	Cell RNA - CAPAN-2 [NX]	Cell RNA - Daudi [NX]	Cell RNA - EFO-21 [NX]	Cell RNA - fHDF/TERT166 [NX]	Cell RNA - GAMG [NX]	Cell RNA - HaCaT [NX]	Cell RNA - HAP1 [NX]	Cell RNA - HBEC3-KT [NX]	Cell RNA - HBF TERT88 [NX]	Cell RNA - HDLM-2 [NX]	Cell RNA - HEK 293 [NX]	Cell RNA - HEL [NX]	Cell RNA - HeLa [NX]	Cell RNA - Hep G2 [NX]	Cell RNA - HHSteC [NX]	Cell RNA - HL-60 [NX]	Cell RNA - HMC-1 [NX]	Cell RNA - HSkMC [NX]	Cell RNA - hTCEpi [NX]	Cell RNA - hTEC/SVTERT24-B [NX]	Cell RNA - hTERT-HME1 [NX]	Cell RNA - hTERT-RPE1 [NX]	Cell RNA - HUVEC TERT2 [NX]	Cell RNA - JURKAT [NX]	Cell RNA - K-562 [NX]	Cell RNA - Karpas-707 [NX]	Cell RNA - LHCN-M2 [NX]	Cell RNA - MCF7 [NX]	Cell RNA - MOLT-4 [NX]	Cell RNA - NB-4 [NX]	Cell RNA - NTERA-2 [NX]	Cell RNA - OE19 [NX]	Cell RNA - PC-3 [NX]	Cell RNA - REH [NX]	Cell RNA - RH-30 [NX]	Cell RNA - RPMI-8226 [NX]	Cell RNA - RPTEC TERT1 [NX]	Cell RNA - RT4 [NX]	Cell RNA - SCLC-21H [NX]	Cell RNA - SH-SY5Y [NX]	Cell RNA - SiHa [NX]	Cell RNA - SK-BR-3 [NX]	Cell RNA - SK-MEL-30 [NX]	Cell RNA - SuSa [NX]	Cell RNA - T-47d [NX]	Cell RNA - THP-1 [NX]	Cell RNA - TIME [NX]	Cell RNA - U-138 MG [NX]	Cell RNA - U-2 OS [NX]	Cell RNA - U-2197 [NX]	Cell RNA - U-251 MG [NX]	Cell RNA - U-266/70 [NX]	Cell RNA - U-266/84 [NX]	Cell RNA - U-698 [NX]	Cell RNA - U-87 MG [NX]	Cell RNA - U-937 [NX]	Cell RNA - WM-115 [NX]	Blood RNA - basophil [NX]	Blood RNA - classical monocyte [NX]	Blood RNA - eosinophil [NX]	Blood RNA - gdT-cell [NX]	Blood RNA - intermediate monocyte [NX]	Blood RNA - MAIT T-cell [NX]	Blood RNA - memory B-cell [NX]	Blood RNA - memory CD4 T-cell [NX]	Blood RNA - memory CD8 T-cell [NX]	Blood RNA - myeloid DC [NX]	Blood RNA - naive B-cell [NX]	Blood RNA - naive CD4 T-cell [NX]	Blood RNA - naive CD8 T-cell [NX]	Blood RNA - neutrophil [NX]	Blood RNA - NK-cell [NX]	Blood RNA - non-classical monocyte [NX]	Blood RNA - plasmacytoid DC [NX]	Blood RNA - T-reg [NX]	Blood RNA - total PBMC [NX]	Brain RNA - amygdala [NX]	Brain RNA - basal ganglia [NX]	Brain RNA - cerebellum [NX]	Brain RNA - cerebral cortex [NX]	Brain RNA - hippocampal formation [NX]	Brain RNA - hypothalamus [NX]	Brain RNA - midbrain [NX]	Brain RNA - olfactory region [NX]	Brain RNA - pons and medulla [NX]	Brain RNA - thalamus [NX]	Single Cell Type RNA - Alveolar cells type 1 [NX]	Single Cell Type RNA - Alveolar cells type 2 [NX]	Single Cell Type RNA - B-cells [NX]	Single Cell Type RNA - Basal glandular cells [NX]	Single Cell Type RNA - Basal keratinocytes [NX]	Single Cell Type RNA - Bipolar cells [NX]	Single Cell Type RNA - Cardiomyocytes [NX]	Single Cell Type RNA - Cholangiocytes [NX]	Single Cell Type RNA - Ciliated cells [NX]	Single Cell Type RNA - Club cells [NX]	Single Cell Type RNA - Collecting duct cells [NX]	Single Cell Type RNA - Cone photoreceptor cells [NX]	Single Cell Type RNA - Cytotrophoblasts [NX]	Single Cell Type RNA - Distal tubular cells [NX]	Single Cell Type RNA - Ductal cells [NX]	Single Cell Type RNA - Early spermatids [NX]	Single Cell Type RNA - Endothelial cells [NX]	Single Cell Type RNA - Enterocytes [NX]	Single Cell Type RNA - Erythroid cells [NX]	Single Cell Type RNA - Exocrine glandular cells [NX]	Single Cell Type RNA - Extravillous trophoblasts [NX]	Single Cell Type RNA - Fibroblasts [NX]	Single Cell Type RNA - Glandular cells [NX]	Single Cell Type RNA - granulocytes [NX]	Single Cell Type RNA - Hepatocytes [NX]	Single Cell Type RNA - Hofbauer cells [NX]	Single Cell Type RNA - Horizontal cells [NX]	Single Cell Type RNA - Intestinal endocrine cells [NX]	Single Cell Type RNA - Ito cells [NX]	Single Cell Type RNA - Kupffer cells [NX]	Single Cell Type RNA - Late spermatids [NX]	Single Cell Type RNA - Leydig cells [NX]	Single Cell Type RNA - Macrophages [NX]	Single Cell Type RNA - Melanocytes [NX]	Single Cell Type RNA - monocytes [NX]	Single Cell Type RNA - Mucus-secreting cells [NX]	Single Cell Type RNA - Muller glia cells [NX]	Single Cell Type RNA - Pancreatic endocrine cells [NX]	Single Cell Type RNA - Paneth cells [NX]	Single Cell Type RNA - Peritubular cells [NX]	Single Cell Type RNA - Proximal tubular cells [NX]	Single Cell Type RNA - Rod photoreceptor cells [NX]	Single Cell Type RNA - Sertoli cells [NX]	Single Cell Type RNA - Smooth muscle cells [NX]	Single Cell Type RNA - Spermatocytes [NX]	Single Cell Type RNA - Spermatogonia [NX]	Single Cell Type RNA - Suprabasal keratinocytes [NX]	Single Cell Type RNA - Syncytiotrophoblasts [NX]	Single Cell Type RNA - T-cells [NX]	Single Cell Type RNA - Undifferentiated cells [NX]	Single Cell Type RNA - Urothelial cells [NX]	RNAsingleCellTypeSpecific
LAMC2	BM600-100kDa, EBR2, EBR2A, kalinin-105kDa, LAMB2T, LAMNB2, nicein-100kDa	ENSG00000058085	Laminin subunit gamma 2	Q13753	1	183186238-183244900	Disease related genes, Plasma proteins, Predicted secreted proteins	Cell adhesion	Heparin-binding	Epidermolysis bullosa	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	4	Pancreatic endocrine cells: 902.6	Cancer enhanced	Detected in many		head and neck cancer: 231.3	Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		A-431: 49.4;CAPAN-2: 44.7;HBEC3-KT: 221.9;hTERT-HME1: 137.0;RPTEC TERT1: 53.2	Low region specificity	Detected in many			Low region specificity	Detected in all			CAB004257, HPA024638, CAB078165	Enhanced		Approved	Cytosol	Secreted to extracellular matrix	No	No			Cytosol		CAB004257: AB_627873, CAB078165: AB_2665800, HPA024638: AB_1852689	unprognostic (7.27e-3)	unprognostic (7.21e-3)	unprognostic (3.24e-1)	unprognostic (6.20e-3)	unprognostic (9.43e-2)	unprognostic (4.94e-3)	unprognostic (4.12e-2)	prognostic unfavorable (4.20e-6)	unprognostic (1.25e-1)	unprognostic (1.72e-1)	prognostic unfavorable (7.11e-5)	unprognostic (2.77e-1)	unprognostic (7.24e-2)	unprognostic (1.47e-1)	unprognostic (2.18e-1)	unprognostic (3.18e-1)	unprognostic (1.26e-1)	2.6	0	1	20.6	4.1	0	11.4	3.6	1.2	8.7	8.4	0.9	2.4	0.9	6.6	2.9	6.5	19	12.8	1.8	0.7	0.1	10.5	0.8	18.3	3.3	1.6	1.1	1.9	2.9	0	7	21.2	1.5	3.7	6.8	0.9	11.2	3.2	1.3	12.8	14.3	1.8	0.7	0.7	7.6	1.9	0.9	3.5	9.8	10	15.6	3.4	4.8	0.9	0.8	1.7	0.5	0.4	0.6	0.1	49.4	2.2	0	0	0.4	1.1	3.6	0.3	0.4	0.1	0	3.6	44.7	0	19	0.1	1.4	22.3	0	221.9	0.2	0	0	0	0	0	0.1	0	0	0.5	17.2	0.5	137	0.2	2.9	0	0	0	0.2	0.1	0	0	0.4	18.1	3.1	0	0.1	0	53.2	12.9	2.7	0	1.3	0	0	1.4	0.1	0.2	0.3	0.2	2.7	1.3	0.6	0	0	0	0.3	0	0	1.4	0.4	0.6	0.4	0.3	0.4	0.5	0.4	0.4	0.1	0.9	0.5	0.6	1.7	0.4	0.5	0.8	0.3	0.1	1	4.1	3.6	1.2	0.7	0.1	1.6	1.1	1.5	0.9	202.5	19.1	0	163.7	76.6	0	1.1	15.3	66.9	51.2	22.7	0	26.6	0	197.8	16.4	0.5	28.1	0	81.6	9.8	7.8	209.4	0	0	2.2	0	8.6	0	0	8.3	3.1	2.9	8.5	4.6	13	0	902.6	26	0.4	0	0	0	2.3	3.7	1	26	69.7	0.7	7.1	119.2	Pancreatic endocrine cells
GAD2	GAD65	ENSG00000136750	Glutamate decarboxylase 2	Q05329	10	26216307-26304558	Enzymes, Predicted intracellular proteins	Neurotransmitter biosynthesis	Decarboxylase, Lyase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	brain: 66.2	Cell type enriched	Detected in some	11	Pancreatic endocrine cells: 35.1	Group enriched	Detected in some	21	glioma: 0.7;pancreatic cancer: 3.0;testis cancer: 1.2	Region enhanced	Detected in all		basal ganglia: 66.2	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	12	MOLT-4: 5.2;SCLC-21H: 11.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA044637, CAB078177	Enhanced											CAB078177: AB_2665779, HPA044637: AB_10794053		unprognostic (8.67e-2)			unprognostic (1.11e-1)						unprognostic (4.93e-2)		unprognostic (2.52e-5)	unprognostic (5.44e-2)	unprognostic (8.08e-2)			1	0.9	6.3	0.9	66.2	1	0.9	5.6	28.7	0.9	0.9	1.4	0	1.2	0.9	1.1	0.9	0.9	0.9	0.9	5.2	13.2	1	0.9	0.9	0.9	5.4	10	0.9	12.9	0.9	0.4	0.9	6.8	1.2	1	0	0.9	0.9	0.9	1.3	1.1	0.9	1.3	0.9	1.2	1.7	8.1	0	0.9	0	0.9	1	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0.3	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	5.2	0	0.1	0	0	0	0	0	0	0	11.7	0.1	0	0	0	0.6	0	0	0	0	0.6	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	6.3	66.2	5.6	18.2	5.2	13.2	5.4	10	6.8	8.1	0	0	0	0	0	2	0.4	0	0	0	0	0	0	0	0	1.4	0	0	0	0.6	0	0	0	0	0	0	3.2	1.7	0	0	0	0	0	0	0	0	0.5	35.1	0	0	0	0.4	0	0	0.4	0.1	0	0	0	0	0	Pancreatic endocrine cells
SHISAL2B	FAM159B	ENSG00000145642	Shisa like 2B	A6NKW6	5	64690308-64718090	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enhanced	Detected in some		brain: 7.3;pancreas: 16.1;stomach 1: 7.7	Cell type enriched	Detected in single	16	Pancreatic endocrine cells: 1.6	Cancer enriched	Detected in some	7	pancreatic cancer: 3.9	Group enriched	Detected in some	14	basal ganglia: 1.9;hypothalamus: 7.3;pons and medulla: 4.9	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	NTERA-2: 5.9;RPTEC TERT1: 12.4	Not detected	Not detected			Low region specificity	Detected in all			HPA011778	Enhanced											HPA011778: AB_1848382	unprognostic (5.83e-2)	unprognostic (9.32e-2)	unprognostic (1.40e-1)	unprognostic (1.84e-2)	unprognostic (3.25e-1)	unprognostic (5.01e-2)		unprognostic (1.49e-1)		unprognostic (9.12e-2)	unprognostic (2.97e-1)	unprognostic (4.84e-2)	unprognostic (5.36e-5)	unprognostic (1.44e-1)	unprognostic (1.98e-1)	unprognostic (5.60e-1)	unprognostic (6.99e-2)	0.1	0	0.3	0	1.9	0	0	0	0.3	0	0.2	0	0	0.6	0	0	0	0	0	0	0.3	7.3	0.2	0	0.2	0	0.2	0	0.2	16.1	0	0.1	0.5	4.9	0.1	0	3.2	0	0	0	0	0.2	0	0	0	7.7	0.6	0.2	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.9	0	0	0	0	0	12.4	0	2.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	1.9	0	0.2	0.3	7.3	0.2	0	4.9	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	Pancreatic endocrine cells
TFF1	BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2	ENSG00000160182	Trefoil factor 1	P04155	21	42362282-42366594	Cancer-related genes, Plasma proteins, Predicted secreted proteins		Growth factor	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	34	gallbladder: 247.7;stomach 1: 375.3	Cell type enriched	Detected in many	10	Pancreatic endocrine cells: 8493.3	Group enriched	Detected in many	10	breast cancer: 402.1;colorectal cancer: 268.3;pancreatic cancer: 805.7;stomach cancer: 744.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	41	MCF7: 478.7;OE19: 196.0	Not detected	Not detected							CAB002170, HPA003425	Enhanced				Secreted to digestive system				990000			CAB002170: AB_563985, HPA003425: AB_1848260	prognostic favorable (5.00e-4)	unprognostic (8.81e-3)	unprognostic (9.82e-2)	prognostic favorable (5.67e-4)		unprognostic (2.42e-1)	unprognostic (1.72e-3)	unprognostic (8.14e-2)		unprognostic (2.45e-1)	unprognostic (1.52e-1)	unprognostic (6.62e-2)		unprognostic (1.01e-1)	unprognostic (1.19e-1)	unprognostic (7.72e-3)	unprognostic (1.07e-1)	0.1	0	0.1	1	0.2	0	3.5	0.1	0.1	0.5	4.9	1.4	0.1	1.4	0.1	0.1	1.1	0.1	247.7	0.1	0.1	0	0.1	0.3	0.5	0.1	0.1	0.1	0.1	0.9	0	0.1	0.1	0.1	1.9	4.7	0.1	5	0.2	0.1	0	5.6	0.1	0.1	0.1	375.3	0.1	0.1	0.1	0.2	1.1	9.2	1	0.2	0	0	0	0	0	0	0	0	1.5	0	0	0	0	0.1	0	0	0	0	0.5	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	478.7	0.1	0	0.2	196	8.2	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	6.4	0	0	0	830.5	0	0	33.2	0	0	0	88.4	0	0	116.3	0	741.5	3	0	273.3	13.8	0	0.2	0	413.6	0	0	0	0	0	0	18	404.2	0	8493.3	152.5	0	0	0	0	0	0	0	0	0.2	0	47.2	76.6	Pancreatic endocrine cells
LCE3D	LEP16, SPRL6A, SPRL6B	ENSG00000163202	Late cornified envelope 3D	Q9BYE3	1	152579381-152580504	Predicted intracellular proteins	Keratinization			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		cervix, uterine: 53.2;lymphoid tissue: 48.6;tongue: 96.6;vagina: 48.5	Cell type enriched	Detected in single	36	Pancreatic endocrine cells: 5.0	Group enriched	Detected in many	9	head and neck cancer: 126.9;melanoma: 47.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	hTCEpi: 8.7;hTERT-HME1: 8.1																							unprognostic (1.34e-1)				unprognostic (1.09e-1)			unprognostic (2.87e-1)									0.3	0	0.1	0.1	0.1	0	0.3	0.1	0.1	53.2	0.1	0.1	0.1	0	3.7	0.1	7.8	0.1	0.2	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	8.5	0.1	0.1	17	0.1	0.1	0.1	0.1	0	0.1	0.1	0.9	0.1	96.6	48.6	0.1	48.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.4	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0.2	0	0	0	0	0	0	8.7	0	8.1	0	0	0	0.1	0	0.2	0	0	0	0	0	0.3	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	1.3	0	0	0.1	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	Pancreatic endocrine cells
GKN1	AMP18, BRICD1, CA11	ENSG00000169605	Gastrokine 1	Q9NS71	2	68974573-68980974	Plasma proteins, Predicted secreted proteins		Mitogen		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	41	stomach 1: 918.9	Cell type enriched	Detected in some	61	Pancreatic endocrine cells: 201.5	Cancer enriched	Detected in some	116	stomach cancer: 255.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HaCaT: 5.2;HMC-1: 14.2;MOLT-4: 9.9;NTERA-2: 13.5;REH: 5.8;U-2 OS: 8.8;U-266/70: 8.8	Low region specificity	Detected in single			Not detected	Not detected			HPA047684	Enhanced				Secreted to digestive system				26000000			HPA047684: AB_2680120						unprognostic (5.40e-2)					prognostic unfavorable (1.54e-4)			unprognostic (4.54e-1)			prognostic favorable (4.53e-4)	0	0	0	0	0.1	0	0	0	0.4	0	0	11.9	0	0	0	0	0.8	0	0.7	0	0	0	0	0.3	0	0	0	0	0	0.3	0	0	22.4	0	2	0	0	3	0	0	0	0	1.4	0	0.2	918.9	0	0	1	0	0	0	5.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.4	0	0	0	0	0.2	0	0	5.2	0	0.1	0	0	0	0	0.6	0	0	0	14.2	0	0	0	0	0	0	0	0	0	0.2	0	9.9	0	13.5	0	0	5.8	0	0	0	0	0.1	0	0	0	0	0	0	1	0.2	0	8.8	0	0	8.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	3.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	201.5	0	0	0	0	0	0	0	0	0	0.1	0	0	0	Pancreatic endocrine cells
REG3A	HIP, PAP, PAP1, PBCGF, REG-III, REG3	ENSG00000172016	Regenerating family member 3 alpha	Q06141	2	79157003-79159753	Plasma proteins, Predicted secreted proteins, Transporters	Acute phase, Inflammatory response	Antimicrobial		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	62	intestine: 354.2;pancreas: 502.4	Cell type enriched	Detected in some	5	Pancreatic endocrine cells: 8841.0	Cancer enhanced	Detected in some		pancreatic cancer: 710.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 12.4;EFO-21: 11.8;HDLM-2: 10.9;NB-4: 12.2;RPMI-8226: 15.7;SH-SY5Y: 10.2;U-2 OS: 19.4;U-251 MG: 7.2;U-266/84: 10.2									HPA047894, HPA048334, HPA060705	Supported		Approved	Cytosol	Secreted to digestive system				22000000	Cytosol		HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346			unprognostic (2.43e-2)				unprognostic (2.12e-1)				unprognostic (3.62e-2)			unprognostic (1.42e-1)				0.2	0.4	0.2	0.4	0.2	0	0.2	0.2	0.2	0.2	73.1	0.2	0.2	276.3	0.2	0.2	0.2	0	1.1	0.2	0.2	0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	502.4	0	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	354.2	0.2	0.2	0.2	6.9	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	12.4	0	0	0	0	0	0	0	11.8	0	0	0	0	0	0	10.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.2	0.1	0.2	0	0	0	15.7	0	0	1.2	10.2	0	0	0	0	0	0.1	0	0	19.4	3.8	7.2	0	10.2	2.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	121.8	4.3	0	5.2	0	1666.7	0	0	0	0	0	0	0	0	0	0	3.1	0	0	0	97.4	19.1	0	8841	0	0	0	0	0	0	0	0	0	0	0	0.6	0	Pancreatic endocrine cells
MYEOV	OCIM	ENSG00000172927	Myeloma overexpressed	Q96EZ4	11	69294138-69367726	Predicted membrane proteins			Proto-oncogene	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		adipose tissue: 29.4;breast: 16.9;esophagus: 17.3	Cell type enriched	Detected in some	8	Pancreatic endocrine cells: 116.0	Low cancer specificity	Detected in many			Not detected	Not detected			Cell type enhanced	Detected in single		NK-cell: 1.0	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		A-431: 59.2;A549: 28.4;CAPAN-2: 8.7;U-2 OS: 13.1									HPA012949	Uncertain		Approved	Nucleoplasm,Vesicles						Nucleoplasm	Vesicles	HPA012949: AB_1854241	unprognostic (1.42e-2)	unprognostic (8.56e-2)	unprognostic (7.07e-2)	unprognostic (3.36e-1)	unprognostic (5.60e-2)	unprognostic (7.28e-3)	unprognostic (7.58e-3)	prognostic unfavorable (2.00e-4)	unprognostic (3.49e-1)	unprognostic (6.33e-2)	prognostic unfavorable (1.54e-7)	unprognostic (2.83e-1)	prognostic unfavorable (1.48e-5)	unprognostic (2.08e-1)	unprognostic (1.16e-1)	unprognostic (3.35e-1)	unprognostic (3.69e-2)	29.4	0.2	0	2.4	0	0.2	16.9	0.1	0	2.6	1.1	0	0.4	0.4	0.5	8.1	17.3	0	1.3	0.1	0	0.2	0.2	8.6	0.1	0.2	0	0.1	0.1	2.1	0	0.1	0	0	0.1	0.6	0.9	2	0	0.6	4.9	0.8	0.1	0	0.3	10.7	0.4	0	0.1	0.1	5.3	13.6	0.2	4.7	0.5	0	0	0.1	1	0.3	2.1	59.2	28.4	0	0	0	0	0.8	0.1	0	0	0	0.2	8.7	0.2	2.6	0	0	0.8	0	0	0	0	0	0	0.2	0.1	0	0	2.4	0	0	0	0	0	2.8	0	0.8	0	0	1.2	0	0	0	1	2.3	0	0	1	0.2	0	0	0	0	0.8	0.1	0	1	0.1	0.8	0	13.1	0	0.6	0.1	0.6	0.1	0	0.2	1.1	0	0.1	0	0.2	0	0.3	0.5	0	0.1	0	0	0	0.1	0	1	0	0	0	2.1	0	0	0.1	0	0	0.2	0	0.1	0	0	0	0	0	0.6	0.7	0	0.3	0	0	0	3.5	0	0	0	15.5	10.5	0	0.4	0	8.4	0.2	0.2	1.2	0	0	2.4	0	0	0	0	4.7	0.3	0	0	0	1	0	116	12.5	0	0	0	0	1.4	0	0.4	1.1	0.1	0	0.5	6.8	Pancreatic endocrine cells
RFLNA	Cfm2, FAM101A, FLJ44614, RefilinA	ENSG00000178882	Refilin A	Q6ZTI6	12	123973241-124316024	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	stomach 1: 118.3	Cell type enriched	Detected in some	24	Pancreatic endocrine cells: 66.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	hTEC/SVTERT24-B: 9.0;HUVEC TERT2: 12.8;LHCN-M2: 22.4;OE19: 23.3;RH-30: 7.3					Low region specificity	Detected in all			HPA058911, HPA078021	Enhanced		Approved	Nucleoplasm,Golgi apparatus						Nucleoplasm	Golgi apparatus	HPA058911: AB_2683853, HPA078021: AB_2732368	unprognostic (1.71e-1)	unprognostic (6.85e-2)	unprognostic (1.63e-2)	unprognostic (1.36e-1)	unprognostic (3.15e-2)	unprognostic (8.78e-4)	unprognostic (2.01e-1)	prognostic unfavorable (3.16e-5)	unprognostic (8.87e-2)	unprognostic (1.59e-1)	unprognostic (1.71e-3)	unprognostic (1.15e-3)	unprognostic (1.77e-8)	unprognostic (2.48e-1)	unprognostic (1.36e-1)	unprognostic (6.27e-2)	unprognostic (1.37e-2)	5.5	3	6.4	5.2	8.6	2.6	8.2	10.8	6.6	11.7	20.9	9.7	7	19.5	4.8	4.8	3	5.5	3.7	5.1	6.3	6.3	5.4	5.3	3.2	2.8	9.8	5.2	5.2	7.6	2.7	9.4	3.4	9	6.3	15.4	6.3	8.7	5.4	8.5	4.2	20.7	3.4	8.3	2.8	118.3	2.7	8.3	1.9	9.6	2.3	2.8	3.3	4.3	0	0	0	0	0	0.3	0	0	0	1.7	0	0	0	2.3	0	0	0.3	0.3	1.1	0.8	0	0.1	3.1	0.1	0	1.3	0	0.1	0	0.1	0	0	0	0.6	0	0.1	0.5	0	9	0	0.5	12.8	1.3	0	0	22.4	0	0	0	1.9	23.3	0	0	7.3	0.1	0	0	0.9	0.6	0	0	0	0.5	0	0	0.1	0	0.1	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	6.4	8.6	10.8	6.6	6.3	6.3	9.8	5.2	9	8.3	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	2.7	0	0	0	0	2.3	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	66.2	0	0	0	0	0	0	0	0	0	0	0	0	0	Pancreatic endocrine cells
FAM25G	bA301J7.4	ENSG00000189090	Family with sequence similarity 25 member G	B3EWG6	10	47487219-47491693	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level		Tissue enriched	Detected in some	7	skin 1: 42.4	Cell type enriched	Detected in some	8	Pancreatic endocrine cells: 33.4	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	28	SK-BR-3: 22.5									HPA044808	Uncertain											HPA044808: AB_2679096						unprognostic (1.97e-2)												0	0	0	0	0	0	2.7	0	0	3.8	0			0	0	0	5.7	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		1.7	0	0	42.4	0.7	0	0	0	0	0			0		1.7	0	3.5	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	22.5	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.4	0.2	0	0	0	2.8	0	0	0	0	0	0.1	0	0	0	0	0.9	0.3	0	0	0	0.3	0	33.4	0	0	0	0	0	0	0	0.9	0	0.3	0	0	0	Pancreatic endocrine cells
MMP1	CLG	ENSG00000196611	Matrix metallopeptidase 1	P03956	11	102789920-102798160	Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Collagen degradation, Host-virus interaction	Hydrolase, Metalloprotease, Protease	Cancer-related genes, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		gallbladder: 62.4;stomach 1: 27.2	Cell type enriched	Detected in some	7	Pancreatic endocrine cells: 1303.6	Cancer enhanced	Detected in many		head and neck cancer: 344.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ hTERT+: 90.2;HBF TERT88: 89.3;HUVEC TERT2: 234.8;WM-115: 115.7									HPA004920			Approved	Vesicles	Secreted to extracellular matrix			7730000	430000	Vesicles		HPA004920: AB_2667293	unprognostic (4.11e-3)	prognostic unfavorable (4.66e-4)	unprognostic (4.20e-3)	unprognostic (1.19e-3)	unprognostic (6.46e-2)	unprognostic (6.50e-2)	prognostic unfavorable (4.22e-6)	unprognostic (7.83e-3)	unprognostic (2.94e-2)	unprognostic (5.44e-2)	unprognostic (1.11e-3)	unprognostic (1.75e-1)	prognostic unfavorable (9.86e-10)	unprognostic (1.67e-2)	unprognostic (1.49e-1)	unprognostic (1.26e-2)	unprognostic (5.11e-2)	0.2	0.1	0.3	12.3	0.3	0	0.9	0.3	0.3	0.3	2.7	0.3	0.2	3.2	4.8	0.2	3.3	0.1	62.4	0.4	0.2	0.1	0.7	1.3	4.7	0.2	0.2	0.2	0.2	1.6	0	0.2	8.6	0.5	0.7	3	0.3	2	0.2	0.2	0.3	8.8	0.2	0.4	1.8	27.2	2.2	0.2	0.4	0.3	1.3	0.9	11	0.2	0	0	0.6	0	0	0	1.9	0	0	0	0	0	0	0	40.8	90.2	36.9	9.6	0.7	0	0	0.4	21.6	14.2	0.3	0	12.6	89.3	0	0	0	0	0	0.2	0	0	0	0	37.9	3.2	0	234.8	0	0.1	0	0	0	0	0	0	14.7	1.6	0	0	0	0	0.1	0	0	0.3	0	0.1	0	0	0	12.1	30.6	0	1.3	0.1	0	0	0	0.7	0	115.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	1.9	0.3	0.3	0.3	0.3	0.2	0.1	0.2	0.2	0.5	0.2	3	1.6	0	14.4	2.1	0	0	35.7	0	23.9	3.5	0	0	0	3.5	0	0.1	0	0	184	0	0.2	5.4	0	0	0.3	0	0	0	1.9	0	0	0.2	0	7.2	0	0	1303.6	0	0	0	0	0	0.4	0	0	0.3	0.1	0	0	25	Pancreatic endocrine cells
CYSRT1	C9orf169, MGC59937	ENSG00000197191	Cysteine rich tail 1		9	137224635-137226311	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in many	4	esophagus: 33.4	Cell type enriched	Detected in some	6	Pancreatic endocrine cells: 33.8	Cancer enhanced	Detected in all		head and neck cancer: 23.0	Low region specificity	Detected in many			Cell type enhanced	Detected in some		non-classical monocyte: 3.0	Low lineage specificity	Detected in single			Cell line enhanced	Detected in many		A-431: 10.0;CAPAN-2: 12.7;HaCaT: 14.1;HeLa: 12.5;MCF7: 19.6	Not detected	Not detected			Low region specificity	Detected in all			HPA021883, HPA021886	Approved		Approved	Nuclear speckles,Vesicles,Midbody		Yes	No			Nuclear speckles	Vesicles, Midbody	HPA021883: AB_1853190, HPA021886: AB_1853192	unprognostic (1.35e-1)	unprognostic (2.53e-2)	unprognostic (8.31e-3)	unprognostic (6.87e-3)	unprognostic (2.14e-1)	unprognostic (2.66e-2)	unprognostic (8.11e-2)	unprognostic (5.86e-2)	unprognostic (3.45e-1)	unprognostic (2.73e-1)	unprognostic (1.24e-2)	unprognostic (1.05e-1)	unprognostic (6.24e-3)	unprognostic (7.92e-3)	unprognostic (1.99e-1)	unprognostic (1.03e-1)	unprognostic (2.29e-1)	0.7	0.4	1	0.7	0.9	0.2	0.8	0.7	1.7	1.4	0.7	0.7	0.7	0.3	0.7	0.7	33.4	1	0.7	0.7	1.4	1.3	1.4	0.7	0.7	0.7	0.8	0.7	0.7	0.7	0.3	3.5	0.7	0.7	1.1	0	0.7	2.2	0.7	0.7	8.1	0.7	0.7	0.7	0.7	0.8	2.2	0.7	0.7	1.3	0.7	5.3	0.7	2.1	0.9	0.6	0.9	3	0.9	0.3	0.1	10	1.2	1	2.1	0	0.1	2.8	0.3	0.3	0.4	0.2	0.7	12.7	0.7	0.8	0.2	0.4	14.1	0.3	3.2	0	1.3	1	0.2	12.5	6.6	0.7	0.1	0.6	0.3	1.5	0.4	0.1	0.7	0.1	1	0.4	2.2	0.8	19.6	0.4	0.7	0.5	2	1.5	1.5	1.3	1.7	0.5	0.7	0.3	1	2.1	1.8	0.5	0.7	4	0.2	0.5	0.8	0.5	1.8	0.3	1.2	0.9	0.7	0.8	0.6	0.8	0.9	0.2	0.2	0.3	1.7	0.1	0.9	0.3	0.2	0.6	0.8	0.2	0.3	0.7	0.9	3	0.4	0.2	0.1	1	0.9	0.7	1.7	1.4	1.3	0.8	0.7	0.7	0.7	0	0.6	0	0.2	0	0.1	0.2	0	0	4.5	5.2	0	0.4	0	1.1	0.5	0	0.4	0	5.1	0.2	0	0.2	0	0	0.2	0	0	0.6	0.3	0	0	0	0	0	0	0.5	33.8	0	0.4	0.5	0.5	0	0.2	1.9	0.3	0	0	0	0.2	1.1	Pancreatic endocrine cells
INS	IDDM1, IDDM2	ENSG00000254647	Insulin	P01308	11	2159779-2161341	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins	Carbohydrate metabolism, Glucose metabolism	Hormone	Cancer-related genes, Diabetes mellitus, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	193	pancreas: 514.0	Cell type enriched	Detected in some	21	Pancreatic endocrine cells: 2404.6	Cancer enriched	Detected in single	7166	pancreatic cancer: 1751.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	9	EFO-21: 53.7;U-2 OS: 70.4;U-698: 22.2					Region enriched	Detected in single	13	midbrain: 1.7	CAB000048, HPA004932, CAB012098, CAB053843	Enhanced				Secreted to blood			437000				CAB000048: , CAB012098: AB_300968, CAB053843: AB_620123, HPA004932: AB_1851816											unprognostic (7.61e-2)							0.4	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.7	0.1	0.3	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0	1.4	0.1	0.1	0.1	0.1	0.1	0.1	514	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	2.6	0.1	0.1	0.1	0.1	1.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	53.7	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	1.8	0	0	0	0	0	0	0	0	0	70.4	0	5.4	0	2.4	22.2	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.8	0	0	0	0	23.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	117.2	0	0	2404.6	0	0	0	0	0	0	0	0	0	0	0	0	0	Pancreatic endocrine cells
AC008687.4		ENSG00000268655			19	49017496-49020523	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	14	pancreas: 13.7	Cell type enriched	Detected in single	10	Pancreatic endocrine cells: 2.3	Low cancer specificity	Detected in some							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HDLM-2: 2.7;HEK 293: 4.0;SiHa: 2.7;U-2 OS: 3.1;U-251 MG: 2.7																						unprognostic (2.06e-1)	unprognostic (7.61e-3)	unprognostic (7.17e-3)	unprognostic (1.12e-2)	unprognostic (2.93e-1)	unprognostic (1.23e-1)		unprognostic (5.63e-2)	unprognostic (4.91e-2)	unprognostic (3.85e-1)	unprognostic (7.96e-4)	unprognostic (9.37e-3)	unprognostic (4.19e-2)	unprognostic (2.72e-2)	unprognostic (1.33e-1)	unprognostic (6.96e-2)	unprognostic (1.46e-1)	0	0		0		0	0		0	0	0			0.2	0	0	0	0	0	0			0	0	0	0			0	13.7	0		0		0	0		0	0	0	0	0	0		0	0.4	1			0		0	0		0	0	0	0.2	0	0.8	0	0.6	0.2	0	0.6	0.2	0	0.7	0.3	0.1	0	0	0.6	1.3	0.8	0.1	0.3	0	0.3	0.1	0	0.1	2.7	4	0	0.4	0.1	0.1	0.7	0.6	0	0.1	0.1	0	0	0	0.4	0.7	1.5	0	0.2	0	0.2	0.2	0.2	0.1	1.5	0.4	1.2	0	0.1	0.4	0.2	2.7	0.2	0.2	0.1	0.3	0.3	0	0.7	3.1	0	2.7	1.2	2.2	1.2	0.6	1.1	0	0	0.2	0	0.3	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0.8	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.3	0	0	0	0	0	0	0	0	0	0	0	0	0	Pancreatic endocrine cells
LYNX1-SLURP2		ENSG00000284505	LYNX1-SLURP2 readthrough		8	142764334-142778224	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in many		brain: 13.1;esophagus: 13.6	Cell type enriched	Detected in single	9	Pancreatic endocrine cells: 5.9									Group enriched	Detected in some	5	intermediate monocyte: 2.7;non-classical monocyte: 4.1	Lineage enriched	Detected in single	6	monocytes: 4.1	Cell line enhanced	Detected in some		A549: 2.3;BJ: 3.6;EFO-21: 3.0;HaCaT: 2.6;SH-SY5Y: 1.7;TIME: 1.7														Intracellular and membrane																									3.8	2.4	3.7	0.8	4.1	0.3	1.1	1.2	13.1	1.1	1.4	2.1	0	1.1	1.9	1.4	13.6	2.1	1.2	7	3		1.6	6.5	1.1	0.6	2.3	4.2	1.6	1	1.2	0	0.7	6.7	3.6	0.9	1.9	2	5	2	8.6	1.5	3.5	1.2	1.5	1.2	0.8	1.4	0	0.5	0.5	1.1	4.2	0.8	0	0.2	0	4.1	0	0.6	0.1	0	2.3	0	0	0	0	0	3.6	0	0.1	0.4	0.3	0	0	3	0	1	2.6	0	0	0	0	0	0	0	0.7	0.3	0	1.3	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.5	0.9	0.1	0	0	0	0	0	0.4	1.7	0.4	0.2	0	0.1	1.1	0	1.7	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0.3	2.7	0.1	0	0	0.1	0.2	0	0.6	0.2	0	0	4.1	0	0	0.1											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.9	0	0	0	0	0	0	0	0	0	0	0	0	0	Pancreatic endocrine cells
